Ethyl 2-amino-6-(3,5-dimethylisoxazol-4-yl)-5-methoxy-1H-indole-3-carboxylate, 98%, 5g

(1alpha,3alpha,5alpha)-1,3,5-Cyclohexanetricarbonitrile>98.0%(GC)1g

[1-(IODOMETHYL)-2-OXABICYCLO[2.2.2]OCTAN-4-YL]METHANOL, 95%, 100mg

2-(5-FLUORO-1H-INDOL-3-YL)ETHANOL, 95.0%, 10g

(5-Chloropyrimidin-4-yl)hydrazine, 97%, 100mg

tert-Butyl (7R,8aS)-7-hydroxy-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate, 98+%, 1g

N-[3-oxo-3-[[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]amino]propyl]-4-(trifluoromethoxy)-benzamide, 100mg

5-Bromo-2-hydroxy-3-nitropyridine, 98.0%, 5g

Ethyl 4-aminopyrimidine-2-carboxylate, 95.0%, 5g

Pastillas de óxido de titanio(III) de 8-9 mm de diámetro x 6-7 mm 100 g

1-Chloro-3,4-methylenedioxybenzene, 95.0%, 25g

2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine, 95.0%, 10g

N1-(tert-Butoxycarbonyl)-4-fluoro-1,2-phenylenediamine>98.0%(T)1g